A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing

References

• Kisel MA, Kulik LN, Tsybovsky IS, Vlasov AP, Vorob’yov MS, Kholodova EA et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm 2001;216:105–114.
   PubMed Web of Science ®Google Scholar
• Prego C, García M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. J Control Release 2005;101:151–162.
   PubMed Web of Science ®Google Scholar
• Yang R, Gao R, Li F, He H, Tang X. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev Ind Pharm 2011;37:139–148.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Ribeiro AJ, Veiga F. Colloidal carrier integrating biomaterials for oral insulin delivery: Influence of component formulation on physicochemical and biological parameters. Acta Biomater 2009;5:2475–2484.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007;59:478–490.
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. Int J Nanomedicine 2007;2:595–607.
   PubMed Web of Science ®Google Scholar
• Gallarate M, Trotta M, Battaglia L, Chirio D. Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation. J Microencapsul 2009;26:394–402.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004;273:29–35.
   PubMed Web of Science ®Google Scholar
• Garcia-Fuentes M, Torres MR, Alonso JM. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloid Surf B 2002;27:159–168.
   Web of Science ®Google Scholar
• Souto EB, Muller RH. Lipid nanoparticles (SLN and NLC) for drug delivery nanoparticles for pharmaceutical applications. Berlin: American Scientific Publishers, 2006, 103–122.
   Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 2005;294:247–259.
   PubMed Web of Science ®Google Scholar
• Harms M, Muller-Goymann CC. Solid lipid nanoparticles for drug delivery. J Drug Deliv Sci Technol 2011;21:89–99.
   Web of Science ®Google Scholar
• Moeller EH, Jorgensen L. Alternative routes of administration for systemic delivery of protein pharmaceuticals. Proteins Therap 2008;5:89–94.
   Google Scholar
• Khafagy el-S, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007;59:1521–1546.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394–1405.
   PubMed Web of Science ®Google Scholar
• Avadi MR, Sadeghi AM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R et al. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine 2010;6:58–63.
   PubMed Web of Science ®Google Scholar
• Carino GP, Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev 1999;35:249–257.
   PubMed Web of Science ®Google Scholar
• Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev 1999;35:199–234.
   PubMed Web of Science ®Google Scholar
• Choi JY, Ramachandran G, Kandlikar M. The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 2009;43:3030–3034.
   PubMed Web of Science ®Google Scholar
• Philbert MA, Sayes CM, Charlene AM. Nanotoxicology. Comprehensive Toxicology. Oxford: Elsevier, 2011, 707–715.
   Google Scholar
• Suh WH, Suslick KS, Stucky GD, Suh YH. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 2009;87:133–170.
   PubMed Web of Science ®Google Scholar
• Müller RH, Gohla S, Keck CM. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm 2011;78:1–9.
   PubMed Web of Science ®Google Scholar
• Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011;1810:361–373.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mehnert W, Souto EB. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery. Int J Clin Pharm 2005, 366, 170–184.
   Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovová S, Boonme P. Lipid nanocarriers-based semisolids: Review on materials and end product formulations. J Drug Deliv Sci Technol 2011;21:43–54.
   Web of Science ®Google Scholar
• Carson H. The ecology of Drosophila breeding sites. Harold Lyon Arboretum Lecture, University of Hawaii, 1971, 1–28.
   Google Scholar
• Gaivão I, Sierra LM, Comendador MA. The w/w+ SMART assay of Drosophila melanogaster detects the genotoxic effects of reactive oxygen species inducing compounds. Mutat Res 1999;440:139–145.
   PubMed Web of Science ®Google Scholar
• Molnar C, Terriente A, Celis J. Drosophila as a model system for genetic and genomic research. Mol Cell Biol 2006;26:2965–2975.
   PubMed Web of Science ®Google Scholar
• Bubliy OA, Loeschcke V. Effect of low stressful temperature on genetic variation of five quantitative traits in Drosophila melanogaster. Heredity 2002;89:70–75.
   PubMed Web of Science ®Google Scholar
• García-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B 2003;27:159–168.
   Web of Science ®Google Scholar
• Cournarie F, Savelli MP, Rosilio V, Bretez F, Vauthier C, Grossiord JL et al. Insulin-loaded W/O/W multiple emulsions: comparison of the performances of systems prepared with medium-chain-triglycerides and fish oil. Eur J Pharm Biopharm 2004;58:477–482.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomedicine 2007;2:743–749.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006;327:153–159.
   PubMed Web of Science ®Google Scholar
• Crystallinity of Dynasan®114 and Dynasan®118 matrices for the production of stable Miglyol®-loaded nanoparticles, 2011 [database on the Internet].
   Google Scholar
• Souto EB, Müller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul 2006;23:377–388.
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005;22:501–510.
   PubMed Web of Science ®Google Scholar
• Rogosic M, Mencer HJ, Gomzi Z. Polydispersity index and molecular weight distributions of polymers. Eur Polym J 1996;32:1337–1344.
   Web of Science ®Google Scholar
• Hirth F. Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets 2010;9:504–523.
   PubMed Web of Science ®Google Scholar
• Lloyd TE, Taylor JP. Flightless flies: Drosophila models of neuromuscular disease. Ann N Y Acad Sci 2010;1184:e1–20.
   PubMed Web of Science ®Google Scholar